Bionano Genomics, Inc. (LON:0A4K)

Market Cap	7.21M
Revenue (ttm)	24.87M
Net Income (ttm)	-101.31M
Shares Out	n/a
EPS (ttm)	-98.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,768
Average Volume	9,566
Open	5.70
Previous Close	5.58
Day's Range	5.19 - 5.88
52-Week Range	0.16 - 1.51
Beta	n/a
RSI	28.30
Earnings Date	Mar 7, 2025

About Bionano Genomics

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearizatio...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 344
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4K

Financial Performance

In 2023, Bionano Genomics's revenue was $36.12 million, an increase of 29.90% compared to the previous year's $27.80 million. Losses were -$232.49 million, 75.3% more than in 2022.

Financial numbers in USD